Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast Carcinomas
Open Access
- 1 May 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 113 (5), 675-682
- https://doi.org/10.1309/0f58-0grx-fk4r-a6va
Abstract
Overexpression and amplification of the HER-2oncogene in patients with breast cancer has correlated with early onset of metastasis, resistance to horKeywords
This publication has 27 references indexed in Scilit:
- Molecular cytogenetics of primary breast cancer by CGHGenes, Chromosomes and Cancer, 1998
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- Optimization of immunohistochemical detection of ERBB2 in human breast cancer: Impact of fixationThe Journal of Pathology, 1994
- Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.Journal of Clinical Oncology, 1992
- Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.Journal of Clinical Oncology, 1992
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.Proceedings of the National Academy of Sciences, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- The subcellular localization of the neu protein in human normal and neoplastic cellsInternational Journal of Cancer, 1989
- The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase ActivityScience, 1986
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985